No Data
Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $25
Hims & Hers Health Options Spot-On: On October 30th, 101.6K Contracts Were Traded, With 290.06K Open Interest
On October 30th ET, $Hims & Hers Health(HIMS.US)$ had active options trading, with a total trading volume of 101.6K options for the day, of which put options accounted for 38.4% of the total
Hims & Hers Health Stock Is Trading Lower Wednesday: Here's Why
Hims & Hers Health Shares Are Trading Lower in Possible Reaction to Ozempic and Wegovy Being Listed as Available by the FDA.
Reported Earlier, 'Novo Nordisk's Ozempic and Wegovy, Long in Shortage, Are Now Listed as Available by FDA; It Remains Unclear How the Update Could Affect Patients as Well as Compounders' - STAT News